Inverse - 🧠 Let’s talk about treatment

Sarah Sloat

Sunday Scaries

Hello! My name is Sarah Sloat and welcome to Sunday Scaries #168. Thanks for reading this chill newsletter for not-chill people. Today’s newsletter topic answers a question many Sunday Scaries readers ask: What new treatments are there for mental health?

Sit back, relax, and remember — if you want to read more articles about the mind-body connection, click here.

This week’s chill icon

This week’s chill icon is Neptune — a planet so chill it’s a literal ice giant. On Wednesday, NASA released this incredible image of Neptune captured by the James Webb Space Telescope.

Have you encountered a chill icon (or icons) IRL or during your internet browsing? If so, I want to hear from you. Send an email over to sundayscaries@inverse.com and you might see them in next week’s newsletter.

Let’s talk about treatment

Ketamine is inching its way toward becoming a mainstream mental health therapy, and a slew of new research suggests it has real potential to treat conditions like depression.

For example, a study published in September in the Journal of Clinical Psychiatry suggests the anesthetic significantly reduced symptoms of depression, anxiety, and suicidal ideation within a cohort of 424 patients who attended ketamine clinics in Virginia. Because the study did not include a control group or systematically assess side effects, it has its limitations — but experts still say the results reinforce why so many researchers are excited about ketamine's potential.

Meanwhile, a separate study also published in September, this time in the American Journal of Psychiatry, found the anti-depressant effects of ketamine may be boosted when individuals who take it are also shown positive words and images. This may be because ketamine seems to open up a “plasticity window” in the brain that helps forge new connections. This result could signal a potential method to extend ketamine’s benefits — ketamine’s effect can diminish in a few weeks after its use, and infusions can be expensive.

As papers like these add to the pile of research on ketamine — and as the need for accessible, effective mental health treatments becomes increasingly obvious — it’s worth reviewing what ketamine is, what it can do, and the role it may play in the future of medicine.

What is ketamine?

Ketamine is an FDA-approved anesthetic. It was developed in 1964 as a replacement for phencyclidine, a hallucinogenic drug that was once used an anesthetic and is now more infamous for its moniker — PCP — and the dangers associated with it.

Research interest in using ketamine to treat psychiatric conditions emerged in the 1970s, and the first formal investigation of the drug began in the 1990s. Ketamine was first found to have a rapid antidepressant effect in a randomized double-blind trial in 2000.

Ketamine is an N-methyl-D-aspartate receptor antagonist, which means it tamps down the activity of these receptors. This inhibition is thought to explain why it works as an anesthetic but over the years scientists have found ketamine causes a wide range of different molecular effects. Research suggests ketamine can prompt neuronal growth while increasing levels of glutamate in the brain. This effect is why ketamine can cause one to be in a dissociative state — it is also why it’s used in medicine and popular as a party drug.

Is ketamine legal?

It’s complicated. It is FDA-approved as an anesthetic — but ketamine is not recognized by the FDA as a mental health treatment. The Drug Enforcement Agency classifies ketamine as a Schedule III narcotic.

In 2019, the FDA approved esketamine for treatment-resistant cases of depression. Esketamine is derived from part of the ketamine molecule; it is more potent so it can be used at a lower dose. Esketamine is delivered via a nasal spray in a clinic — because it can distort your perception, all this is meant to happen under a doctor’s supervision.

But ketamine is sometimes prescribed to some people for “off-label” use — that means it’s legal for a licensed clinician to prescribe ketamine for a use that is not FDA-approved. In these cases, ketamine is typically delivered via intravenous infusion.

When describing off-label use, the FDA notes that: “If you and your healthcare provider decide to use an approved drug for an unapproved use to treat your disease or medical condition, remember that the FDA has not determined that the drug is safe and effective for the unapproved use.”

This loophole is what has allowed the recent proliferation of ketamine “wellness centers” and startups that sell ketamine tablets. But some experts warn that in many cases this application of ketamine is not comparable to what’s observed in studies. In turn, often there are no licensed medical professionals overseeing the administration of ketamine in these situations, and the drug’s use is not typically partnered with psychotherapy or another intervention.

How can ketamine help mental health?

While some ketamine clinics advertise ketamine as a one-size-fits-all solution for multiple mental health conditions, the science is more limited.

The research is most robust when it comes to treatment-resistant depression. This is when a person diagnosed with major depressive disorder does not respond to anti-depressants after at least six weeks of use. It can be a life-threatening condition and is experienced by an estimated one-third of patients with depression.

Studies have also found ketamine can reduce the severity of depression in people with suicidal ideation, which in turn prompted them to be less likely to harm themselves.

Research also suggests it rapidly confers these benefits and is safe in the short term. Because the therapeutic delay associated with other anti-depressants can put patient safety at risk, the fast-acting nature of ketamine is a large part of its appeal.

Scientists are hopeful that further studies will verify its use as a multi-purpose therapeutic treatment and that it eventually can be used to quickly aid people who come to the hospital looking for psychiatric help.

Now look at this oddly satisfying thing

Sunday Scaries reader Virginia sent in this very satisfying sight. It shows a storm approaching Aptos, California.

Have you seen something strangely satisfying online or IRL? Then send your best examples to sundayscaries@inverse.com for consideration for next week.

What I’m reading this week

Distract yourself from the scaries with these reads:

Should you take a personalized multivitamin? Why experts have some hesitations.

How one ancient Greek thinking revolutionized math — and possibly started a cult. Here’s what your teacher didn’t tell you about Pythagoras.

New study shows one of Saturn’s icy moons may be extremely habitable. A key ingredient for life may be lurking.

And if it’s midnight and you’re still feeling the scaries…

Meet the new otter at the Monterey Bay Aquarium.

share Inverse Daily

Do you know someone who would enjoy reading Inverse Daily? Take a few minutes to share it with them.

You're receiving this email because you signed up to receive communications from BDG Media. If you believe this has been sent to you in error, please safely unsubscribe.

315 Park Ave. South, New York, NY 10010

Copyright 2022 BDG Media, Inc. All rights reserved.

View in browser

Inverse - 🧠 Let’s talk about treatment

Older messages

💊 Study challenges a longstanding myth about Covid-19 and Vitamin D

☣️ Can science prevent a pandemic?

Make The Game Your Own

🍿 The first “prestige” show in Star Wars history has arrived

👾 Devastating leaks

You Might Also Like

☕ Great chains

Pete Hegseth's confirmation hearing.

Honourable Roulette

📬 No. 62 | What I learned about newsletters in 2024

⚡️ ‘Skeleton Crew’ Answers Its Biggest Mystery

I Tried All The New Eye-Shadow Sticks

How To Stop Worrying And Learn To Love Lynn's National IQ Estimates

☕ Olympic recycling

Ozempic has entered the chat

How a major bank cheated its customers out of $2 billion, according to a new federal lawsuit